Meeremans Marguerite, Van de Walle Gerlinde R, Van Vlierberghe Sandra, De Schauwer Catharina
Comparative Physiology, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium.
Baker Institute for Animal Health, College of Veterinary Medicine, Cornell University, Ithaca, NY, United States.
Front Cell Dev Biol. 2021 May 3;9:651164. doi: 10.3389/fcell.2021.651164. eCollection 2021.
Overuse tendon injuries are a major cause of musculoskeletal morbidity in both human and equine athletes, due to the cumulative degenerative damage. These injuries present significant challenges as the healing process often results in the formation of inferior scar tissue. The poor success with conventional therapy supports the need to search for novel treatments to restore functionality and regenerate tissue as close to native tendon as possible. Mesenchymal stem cell (MSC)-based strategies represent promising therapeutic tools for tendon repair in both human and veterinary medicine. The translation of tissue engineering strategies from basic research findings, however, into clinical use has been hampered by the limited understanding of the multifaceted MSC mechanisms of action. models serve as important biological tools to study cell behavior, bypassing the confounding factors associated with experiments. Controllable and reproducible conditions should be provided to study the MSC healing mechanisms in tendon injuries. Unfortunately, no physiologically representative tendinopathy models exist to date. A major shortcoming of most currently available tendon models is the lack of extracellular tendon matrix and vascular supply. These models often make use of synthetic biomaterials, which do not reflect the natural tendon composition. Alternatively, decellularized tendon has been applied, but it is challenging to obtain reproducible results due to its variable composition, less efficient cell seeding approaches and lack of cell encapsulation and vascularization. The current review will overview pros and cons associated with the use of different biomaterials and technologies enabling scaffold production. In addition, the characteristics of the ideal, state-of-the-art tendinopathy model will be discussed. Briefly, a representative tendinopathy model should be vascularized and mimic the hierarchical structure of the tendon matrix with elongated cells being organized in a parallel fashion and subjected to uniaxial stretching. Incorporation of mechanical stimulation, preferably uniaxial stretching may be a key element in order to obtain appropriate matrix alignment and create a pathophysiological model. Together, a thorough discussion on the current status and future directions for tendon models will enhance fundamental MSC research, accelerating translation of MSC therapies for tendon injuries from bench to bedside.
由于累积性退行性损伤,过度使用导致的肌腱损伤是人类和马类运动员肌肉骨骼疾病的主要原因。这些损伤带来了重大挑战,因为愈合过程通常会导致形成质量较差的瘢痕组织。传统疗法效果不佳,这表明需要寻找新的治疗方法,以恢复功能并尽可能使组织再生至接近天然肌腱的状态。基于间充质干细胞(MSC)的策略是人类和兽医学中肌腱修复的有前景的治疗工具。然而,组织工程策略从基础研究成果转化为临床应用受到了对MSC多方面作用机制理解有限的阻碍。模型作为研究细胞行为的重要生物学工具,可以绕过与实验相关的混杂因素。应提供可控且可重复的条件来研究MSC在肌腱损伤中的愈合机制。不幸的是,迄今为止尚无具有生理代表性的肌腱病模型。目前大多数可用的肌腱模型的一个主要缺点是缺乏细胞外肌腱基质和血管供应。这些模型通常使用合成生物材料,其不能反映天然肌腱的组成。另外,已应用去细胞化肌腱,但由于其组成可变、细胞接种方法效率较低以及缺乏细胞包封和血管化,难以获得可重复的结果。本综述将概述与使用不同生物材料和技术进行支架生产相关的优缺点。此外,还将讨论理想的、最先进的肌腱病模型的特征。简而言之,一个具有代表性的肌腱病模型应具有血管化,并模仿肌腱基质的分层结构,其中细长细胞以平行方式排列并受到单轴拉伸。纳入机械刺激,最好是单轴拉伸,可能是获得适当基质排列并创建病理生理模型的关键要素。总之,对肌腱模型的现状和未来方向进行全面讨论将加强基础MSC研究,加速MSC治疗肌腱损伤从实验室到临床的转化。